These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19281874)

  • 1. Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors.
    Versées W; Goeminne A; Berg M; Vandemeulebroucke A; Haemers A; Augustyns K; Steyaert J
    Biochim Biophys Acta; 2009 Jun; 1794(6):953-60. PubMed ID: 19281874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of a novel purine specific nucleoside hydrolase from Trypanosoma vivax.
    Versées W; Decanniere K; Pellé R; Depoorter J; Brosens E; Parkin DW; Steyaert J
    J Mol Biol; 2001 Apr; 307(5):1363-79. PubMed ID: 11292348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition-state complex of the purine-specific nucleoside hydrolase of T. vivax: enzyme conformational changes and implications for catalysis.
    Versées W; Barlow J; Steyaert J
    J Mol Biol; 2006 Jun; 359(2):331-46. PubMed ID: 16630632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase.
    Goeminne A; Berg M; McNaughton M; Bal G; Surpateanu G; Van der Veken P; De Prol S; Versées W; Steyaert J; Haemers A; Augustyns K
    Bioorg Med Chem; 2008 Jul; 16(14):6752-63. PubMed ID: 18571422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors.
    Goeminne A; McNaughton M; Bal G; Surpateanu G; Van Der Veken P; De Prol S; Versées W; Steyaert J; Haemers A; Augustyns K
    Eur J Med Chem; 2008 Feb; 43(2):315-26. PubMed ID: 17582660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of bicyclic N-arylmethyl-substituted iminoribitol derivatives as selective nucleoside hydrolase inhibitors.
    Berg M; Bal G; Goeminne A; Van der Veken P; Versées W; Steyaert J; Haemers A; Augustyns K
    ChemMedChem; 2009 Feb; 4(2):249-60. PubMed ID: 19115304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-substrate interactions in the purine-specific nucleoside hydrolase from Trypanosoma vivax.
    Versées W; Decanniere K; Van Holsbeke E; Devroede N; Steyaert J
    J Biol Chem; 2002 May; 277(18):15938-46. PubMed ID: 11854281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isozyme-specific transition state inhibitors for the trypanosomal nucleoside hydrolases.
    Parkin DW; Limberg G; Tyler PC; Furneaux RH; Chen XY; Schramm VL
    Biochemistry; 1997 Mar; 36(12):3528-34. PubMed ID: 9132003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iminoribitol transition state analogue inhibitors of protozoan nucleoside hydrolases.
    Miles RW; Tyler PC; Evans GB; Furneaux RH; Parkin DW; Schramm VL
    Biochemistry; 1999 Oct; 38(40):13147-54. PubMed ID: 10529186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor.
    Giannese F; Berg M; Van der Veken P; Castagna V; Tornaghi P; Augustyns K; Degano M
    Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1553-66. PubMed ID: 23897478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-steady-state analysis of the nucleoside hydrolase of Trypanosoma vivax. Evidence for half-of-the-sites reactivity and rate-limiting product release.
    Vandemeulebroucke A; Versées W; De Vos S; Van Holsbeke E; Steyaert J
    Biochemistry; 2003 Nov; 42(44):12902-8. PubMed ID: 14596604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QM/MM molecular dynamics study of purine-specific nucleoside hydrolase.
    Wu R; Gong W; Liu T; Zhang Y; Cao Z
    J Phys Chem B; 2012 Feb; 116(6):1984-91. PubMed ID: 22257300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational study of IAG-nucleoside hydrolase: determination of the preferred ground state conformation and the role of active site residues.
    Mazumder-Shivakumar D; Bruice TC
    Biochemistry; 2005 May; 44(21):7805-17. PubMed ID: 15909995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flexible loop as a functional element in the catalytic mechanism of nucleoside hydrolase from Trypanosoma vivax.
    Vandemeulebroucke A; De Vos S; Van Holsbeke E; Steyaert J; Versées W
    J Biol Chem; 2008 Aug; 283(32):22272-82. PubMed ID: 18519562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the mechanism and energetic contribution of leaving group activation in the purine-specific nucleoside hydrolase from Trypanosoma vivax.
    Barlow JN; Steyaert J
    Biochim Biophys Acta; 2007 Nov; 1774(11):1451-61. PubMed ID: 17936095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer simulations of trypanosomal nucleoside hydrolase: determination of the protonation state of the bound transition-state analogue.
    Mazumder D; Kahn K; Bruice TC
    J Am Chem Soc; 2002 Jul; 124(30):8825-33. PubMed ID: 12137535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition state analogue inhibitors of protozoan nucleoside hydrolases.
    Furneaux RH; Schramm VL; Tyler PC
    Bioorg Med Chem; 1999 Nov; 7(11):2599-606. PubMed ID: 10632070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leaving group activation by aromatic stacking: an alternative to general acid catalysis.
    Versées W; Loverix S; Vandemeulebroucke A; Geerlings P; Steyaert J
    J Mol Biol; 2004 Apr; 338(1):1-6. PubMed ID: 15050818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition state analogue inhibitors of N-ribosyltransferases: new drugs by targeting nucleoside processing enzymes.
    Evans GB; Furneaux RH; Kelly PM; Schramm VL; Tyler PC
    Nucleic Acids Symp Ser (Oxf); 2007; (51):63-4. PubMed ID: 18029587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of new chemotherapeutics against the deadly anthrax disease. Docking and molecular dynamics studies of inhibitors containing pyrrolidine and riboamidrazone rings on nucleoside hydrolase from Bacillus anthracis.
    Guimarães AP; Oliveira AA; da Cunha EF; Ramalho TC; França TC
    J Biomol Struct Dyn; 2011 Feb; 28(4):455-69. PubMed ID: 21142217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.